28 May 2026
bởiJairia Dela Cruz
For patients with atrial fibrillation (AF) who sustained an ischaemic stroke while receiving direct oral anticoagulant (DOAC) therapy, switching to another anticoagulation agent does not yield significant improvements in most clinical outcomes compared with staying on the same agent, according to the results of an emulated target trial.